![]() ![]() The Precision Plus™ Spinal Cord Stimulator System, powered by SmoothWave™ Technology, uses pulses of electricity delivered directly along nerve fibers through the spinal cord to mask pain signals to the brain. Pain is the most common reason Americans seek medical treatment, and many chronic pain patients have found that SCS helps them manage their pain and live better lives.īoston Scientific Neuromodulation is an innovation leader in implantable pain management technology. “The approval of these products expands our portfolio of leads for the Precision Plus System, offering pain management physicians more choices to help optimize pain relief for their patients.” “Our products are designed to meet the unique clinical demands of SCS pain patients,” said Michael Onuscheck, Senior Vice President and President of Boston Scientific’s Neuromodulation Division. “When I want wider contact spacing, these new leads provide that option.” “I have had great results using Boston Scientific’s Linear Lead with tight contact spacing for my chronic pain patients,” said Stephen Pyles, M.D., of the Florida Pain Clinic in Ocala, Florida. The new leads, in combination with the recently launched W4 and D4 lead splitters, provide the broadest range of percutaneous lead configurations in the industry. SCS leads are designed to deliver electrical pulses from an implantable pulse generator to the spinal cord to mask pain signals to the brain. they were launched in Europe and other international markets earlier this year. The Company plans to launch the products immediately in the U.S. The Linear™ 3-4 and Linear™ 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world’s first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. NATICK, Mass., July 29 / PRNewswire-FirstCall/ - Boston Scientific Corporation (NYSE: BSX) today announced U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |